lunes, 1 de junio de 2026
New York TimesDrugs (Pharmaceuticals)

F.D.A. Grants Early Access to Promising Drug for Pancreatic Cancer

Patients with one of the deadliest cancers have been pleading for an unapproved treatment that may prolong their lives.

RR
Rebecca Robbins and Gina Kolata
Redacción · hace 31 días
Lectura 2 min
Patients with one of the deadliest cancers have been pleading for an unapproved treatment that may prolong their lives.

Relacionadas en Drugs (Pharmaceuticals)

Sigue leyendo